CHRNA7 and neuropathy: Furthermore, it has been reported that α7 nicotinic acetylcholine receptor (nAChR) subtype is involved in the oxaliplatin-induced neuropathy, and α7 nAChR-dependent modulation of glial functions improves the pain-related behavior [19].